Published 1996 | Version v1
Journal article

Development of the radiopharmaceuticals for interventional tumor therapy in China

  • 1. Academia Sinica, Beijing, BJ (China). Inst. of Atomic Energy

Description

Shortly after the radioactive radium wa discovered, it made people to try using radio action of Ra in medical therapy of human's diseases. But in the past 60 year, the most interests were concentrated in clinical diagnostic techniques of nuclides. Up to date, nuclear and non-nuclear diagnostic techniques of the tumor are quite advanced, the therapeutic application of 90Y, 226Ra, 198Au and 32P nuclides have lasted for long time, several decades later, the studies of tumor interventional radiotherapeutic agents are being interested again and made a very great progresses with the development of nuclear instrument. In our institute, we are developing some very important radiotherapeutic agents in vivo for the treatment of bone metastases, hepatic cancer, brain tumor, rheumatic arthritis radioactive synovectomy,pheochromocytoma, neuroblastoma and so on. (author). 17 refs., 1 fig., 7 tabs

Additional details

Publishing Information

Journal Title
Journal of Radioanalytical and Nuclear Chemistry
Journal Volume
206
Journal Issue
1
Journal Page Range
p. 17-27.
ISSN
0236-5731
CODEN
JRNCDM

Conference

Title
International Conference on Isotopes.
Dates
7-12 May 1995.
Place
Beijing (China).

INIS

Country of Publication
Hungary
Country of Input or Organization
Hungary
INIS RN
27075030
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference
Descriptors DEI
ALPHA DECAY RADIOISOTOPES; BETA DECAY RADIOISOTOPES; CHINA; IN VIVO; RADIOPHARMACEUTICALS; RADIOTHERAPY; RESEARCH PROGRAMS
Descriptors DEC
ASIA; DRUGS; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MEDICINE; RADIOACTIVE MATERIALS; RADIOISOTOPES; THERAPY